Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 1246129, 12 pages
http://dx.doi.org/10.1155/2016/1246129
Research Article

The Serum Expression of Selected miRNAs in Pulmonary Sarcoidosis with/without Löfgren’s Syndrome

1Laboratory of Immunogenomics, Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
2Department of Respiratory Medicine and TBC, Palacky University, Olomouc, Czech Republic
3Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic

Received 30 August 2016; Accepted 10 November 2016

Academic Editor: Alex Kleinjan

Copyright © 2016 Eva Novosadova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Valeyre, A. Prasse, H. Nunes, Y. Uzunhan, P.-Y. Brillet, and J. Müller-Quernheim, “Sarcoidosis,” The Lancet, vol. 383, no. 9923, pp. 1155–1167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Zissel and J. Müller-Quernheim, “Specific antigen(s) in sarcoidosis: a link to autoimmunity?” European Respiratory Journal, vol. 47, no. 3, pp. 707–709, 2016. View at Publisher · View at Google Scholar
  3. S. L. Ameres and P. D. Zamore, “Diversifying microRNA sequence and function,” Nature Reviews Molecular Cell Biology, vol. 14, no. 8, pp. 475–488, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Kiszałkiewicz, W. J. Piotrowski, D. Pastuszak-Lewandoska et al., “Altered miRNA expression in pulmonary sarcoidosis,” BMC Medical Genetics, vol. 17, no. 1, article 2, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Dyskova, R. Fillerova, T. Novosad et al., “Correlation network analysis reveals relationships between MicroRNAs, transcription factor T-bet, and deregulated cytokine/chemokine-receptor network in pulmonary sarcoidosis,” Mediators of Inflammation, vol. 2015, Article ID 121378, 16 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. E. D. Crouser, M. W. Julian, M. Crawford et al., “Differential expression of microRNA and predicted targets in pulmonary sarcoidosis,” Biochemical and Biophysical Research Communications, vol. 417, no. 2, pp. 886–891, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Jazwa, L. Kasper, M. Bak et al., “Differential inflammatory MicroRNA and cytokine expression in pulmonary sarcoidosis,” Archivum Immunologiae et Therapiae Experimentalis, vol. 63, no. 2, pp. 139–146, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Weber, D. H. Baxter, S. Zhang et al., “The microRNA spectrum in 12 body fluids,” Clinical Chemistry, vol. 56, no. 11, pp. 1733–1741, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. R. Qazi, P. T. Paredes, B. Dahlberg, J. Grunewald, A. Eklund, and S. Gabrielsson, “Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis,” Thorax, vol. 65, no. 11, pp. 1016–1024, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Marabita, P. de Candia, A. Torri, J. Tegnér, S. Abrignani, and R. L. Rossi, “Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR,” Briefings in Bioinformatics, vol. 17, no. 2, pp. 204–212, 2015. View at Publisher · View at Google Scholar
  11. K. W. Witwer, E. I. Buzás, L. T. Bemis et al., “Standardization of sample collection, isolation and analysis methods in extracellular vesicle research,” Journal of Extracellular Vesicles, vol. 2, Article ID 20360, 2013. View at Publisher · View at Google Scholar
  12. “Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 2, pp. 736–755, 1999. View at Publisher · View at Google Scholar
  13. M. B. Kirschner, J. J. B. Edelman, S. C.-H. Kao, M. P. Vallely, N. van Zandwijk, and G. Reid, “The impact of hemolysis on cell-free microRNA biomarkers,” Frontiers in Genetics, vol. 4, article 94, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Kriegova, A. Arakelyan, R. Fillerova et al., “PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells,” BMC Molecular Biology, vol. 9, article 69, pp. 1471–2199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Maertzdorf, J. Weiner III, H.-J. Mollenkopf et al., “Common patterns and disease-related signatures in tuberculosis and sarcoidosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 20, pp. 7853–7858, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Navratilova, E. Novosadova, D. Smitalova, A. Kishore, V. Kolek, and M. Petrek, “Serum and bronchoalveolar exosomal miRNAs in pulmonary sarcoidosis,” European Respiratory Journal, vol. 46, supplement 59, Article ID PA3319, 2015. View at Publisher · View at Google Scholar
  17. M. Forlenza, T. Kaiser, H. F. J. Savelkoul, and G. F. Wiegertjes, “The use of real-time quantitative PCR for the analysis of cytokine mRNA levels,” Methods in Molecular Biology, vol. 820, pp. 7–23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Vandesompele, K. De Preter, F. Pattyn et al., “Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes,” Genome biology, vol. 3, no. 7, Article ID RESEARCH0034, 2002. View at Google Scholar · View at Scopus
  19. C. L. Andersen, J. L. Jensen, and T. F. Ørntoft, “Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets,” Cancer Research, vol. 64, no. 15, pp. 5245–5250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Benjamini and Y. Hochberg, “Controlling the false discovery rate: a practical and powerful approach to multiple testing,” Journal of the Royal Statistical Society, Series B: Methodological, vol. 57, no. 1, pp. 289–300, 1995. View at Google Scholar · View at MathSciNet
  21. J. Trygg and S. Wold, “Orthogonal projections to latent structures (O-PLS),” Journal of Chemometrics, vol. 16, no. 3, pp. 119–128, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Levänen, N. R. Bhakta, P. Torregrosa Paredes et al., “Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients,” The Journal of Allergy and Clinical Immunology, vol. 131, no. 3, pp. 894.e8–903.e8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. T.-P. Lu, C.-Y. Lee, M.-H. Tsai et al., “MiRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets,” PLoS ONE, vol. 7, no. 8, Article ID e42390, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Askling, J. Grunewald, A. Eklund, G. Hillerdal, and A. Ekbom, “Increased risk for cancer following sarcoidosis,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 5, part 1, pp. 1668–1672, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Grados, M. Ebbo, E. Bernit et al., “Sarcoidosis occurring after solid cancer: a nonfortuitous association: report of 12 cases and review of the literature,” Medicine (United States), vol. 94, no. 28, article no. e928, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. B. D. Beutler and P. R. Cohen, “Sarcoidosis in melanoma patients: case report and literature review,” Cancers, vol. 7, no. 2, pp. 1005–1021, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Singla, T. Zhou, K. Javaid et al., “Expression profiling elucidates a molecular gene signature for pulmonary hypertension in sarcoidosis,” Pulmonary Circulation, vol. 6, no. 4, pp. 465–471, 2016. View at Publisher · View at Google Scholar
  28. G. Landskron, M. De La Fuente, P. Thuwajit, C. Thuwajit, and M. A. Hermoso, “Chronic inflammation and cytokines in the tumor microenvironment,” Journal of Immunology Research, vol. 2014, Article ID 149185, 19 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Khoury and N. Tran, “Circulating microRNAs: potential biomarkers for common malignancies,” Biomarkers in Medicine, vol. 9, no. 2, pp. 131–151, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. A. P. Kiess, H. Wang, W. D. Travis, and J. Yahalom, “Sarcoid in cancer patients: clinical characteristics and associated disease status,” Sarcoidosis, Vasculitis and Diffuse Lung Diseases, vol. 32, no. 3, pp. 200–207, 2015. View at Google Scholar · View at Scopus
  31. B. Levänen, Å. M. Wheelock, A. Eklund, J. Grunewald, and M. Nord, “Increased pulmonary Wnt (wingless/integrated)-signaling in patients with sarcoidosis,” Respiratory Medicine, vol. 105, no. 2, pp. 282–291, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Tzouvelekis, P. Ntolios, A. Karameris et al., “Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients,” BMC Research Notes, vol. 5, article 654, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Beirne, P. Pantelidis, P. Charles et al., “Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis,” European Respiratory Journal, vol. 34, no. 6, pp. 1376–1382, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Yamashita, T. Mouri, M. Niisato et al., “Heterogeneous characteristics of lymphatic microvasculatures associated with pulmonary sarcoid granulomas,” Annals of the American Thoracic Society, vol. 10, no. 2, pp. 90–97, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Rastogi, W. Du, D. Ju et al., “Dysregulation of p38 and MKP-1 in response to NOD1/TLR4 stimulation in sarcoid bronchoalveolar cells,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 4, pp. 500–510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Xaus, N. Besalduch, M. Comalada et al., “High expression of p21Waf1 in sarcoid granulomas: a putative role for long-lasting inflammation,” Journal of Leukocyte Biology, vol. 74, no. 2, pp. 295–301, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Massagué, “TGFβ signalling in context,” Nature Reviews Molecular Cell Biology, vol. 13, no. 10, pp. 616–630, 2012. View at Publisher · View at Google Scholar
  38. G. Yang, L. Yang, W. Wang, J. Wang, J. Wang, and Z. Xu, “Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression,” Gene, vol. 562, no. 1, pp. 138–144, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Arakelyan, E. Kriegova, Z. Kubištova et al., “Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis,” Clinical and Experimental Immunology, vol. 155, no. 3, pp. 457–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. N. V. Rivera, M. Ronninger, K. Shchetynsky et al., “High-density genetic mapping identifies new susceptibility variants in sarcoidosis phenotypes and shows genomic-driven phenotypic differences,” American Journal of Respiratory and Critical Care Medicine, vol. 193, no. 9, pp. 1008–1022, 2016. View at Publisher · View at Google Scholar
  41. Z. Navratilova, F. Mrazek, E. Kriegova et al., “The MCP-1-2518 (A to G) single nucleotide polymorphism in Czech patients with pulmonary sarcoidosis: association with Löfgren's syndrome,” Sarcoidosis, Vasculitis, and Diffuse Lung Diseases: Official Journal of WASOG, vol. 24, no. 1, pp. 33–38, 2007. View at Google Scholar
  42. P. Spagnolo, H. Sato, J. Grunewald et al., “A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB10301 are independent genetic risk factors for Löfgren's syndrome,” Journal of Internal Medicine, vol. 264, no. 5, pp. 433–441, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Turchinovich, T. R. Samatov, A. G. Tonevitsky, and B. Burwinkel, “Circulating miRNAs: cell-cell communication function?” Frontiers in Genetics, vol. 4, article id 119, 2013. View at Publisher · View at Google Scholar · View at Scopus